Shareholders approved the five-year re-appointment of MD Ashish Ravi Puravankara from April 1, 2026, with an extended remuneration framework through March 2029, and standard governance disclosures.
AI Assistant
Puravankara Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.